Skip to main navigation Skip to search Skip to main content

The use of Listeria monocytogenes as a DNA delivery vector for cancer gene therapy

Research output: Contribution to journalArticlepeer-review

Abstract

Listeria monocytogenes is an intracellular pathogen that lyses the phagosomal vacuole of infected cells, proliferates in the host cell cytoplasm and can actively enter adjacent cells. The pathogen is therefore well suited to exploitation as a vector for the delivery of DNA to target cells as the lifecycle favors cellular targeting with vector amplification and the potential for cell-to-cell spread. We have recently demonstrated DNA transfer by L. monocytogenes in growing tumors in murine models. Our approach exploited an ampicillin sensitive stain of L. monocytogenes which can be lysed through systemic administration of ampicillin to facilitate release of plasmid DNA for expression by infected mammalian cells. Here, we discuss the implications of this technology and the potential for future improvements of the system.

Original languageEnglish
Pages (from-to)284-287
Number of pages4
JournalBioengineered Bugs
Volume1
Issue number4
DOIs
Publication statusPublished - 2010

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

  1. SDG 3 - Good Health and Well-being
    SDG 3 Good Health and Well-being

Keywords

  • Bactofection
  • Cancer
  • Gene delivery
  • Listeria monocytogenes
  • Luminescence
  • Salmonella
  • Therapy
  • Tumor

Fingerprint

Dive into the research topics of 'The use of Listeria monocytogenes as a DNA delivery vector for cancer gene therapy'. Together they form a unique fingerprint.

Cite this